Produktbild: Evidence-Based Gastroenterology and Hepatology

Evidence-Based Gastroenterology and Hepatology

Aus der Reihe Evidence-Based Medicine

Fr. 380.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

03.09.2010

Abbildungen

3 schwarzweisse Abbilmit 2 FarbabbildungenFarbabb., 90 Tabellen

Herausgeber

John McDonald + weitere

Verlag

John Wiley & Sons Inc

Seitenzahl

824

Maße (L/B/H)

6.1/23/4.2 cm

Gewicht

2528 g

Auflage

3. Auflage

Sprache

Englisch

ISBN

978-1-4051-8193-8

Beschreibung

Rezension

"There is plenty of terrific material in this book. Each chapter provides information that can be used by busy clinicians to make decisions about their patients." (Gastroenterological, 1 March 2011)
"A well written, easily consulted, updated textbook divided into 2 parts . . . written by experts from several countries. Its orientation is mainly to adult medicine." (Pediatric Endocrinology Reviews, 1 June 2011)

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

03.09.2010

Abbildungen

3 schwarzweisse Abbilmit 2 FarbabbildungenFarbabb., 90 Tabellen

Herausgeber

Verlag

John Wiley & Sons Inc

Seitenzahl

824

Maße (L/B/H)

6.1/23/4.2 cm

Gewicht

2528 g

Auflage

3. Auflage

Sprache

Englisch

ISBN

978-1-4051-8193-8

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Evidence-Based Gastroenterology and Hepatology
  • Part One.

    Gastrointestinal Disorders.

    1 Gastroesophageal reflux disease.

    2 Barett's esophagus.

    3 Esophageal motility disorders: achalasia and spastic motor disorders.

    4 Esinophilic esophagitis.

    5 Ulcer disease and helicobacter pylori.

    6 Non-steroidal anti-inflammatory drug-induced gastroduodenal and enteric toxicity.

    7 Non-variceal gastrointestinal hemorrhage.

    8 Functional dyspepsia.

    9 Celiac disease.

    10 Crohn's disease.

    11 Ulcerative colitis.

    12 Pouchitis after restorative proctocolectomy.

    13 Microscopic colitis: collagenous and lymphocytic colitis.

    14 Drug induced Diarreha.

    15 Metabolic bone disease in gastrointestinal disorders.

    16 Colorectal cancer in ulcerative colitis: surveillance.

    17 Colorectal cancer: population screening and surveillance.

    18 Prevention and treatment of travellers' diarrhoea.

    19 Clostridium difficile disease.

    20 Irritable bowel syndrome.

    21 Ogilvie's syndrome.

    22 Gallstone disease.

    23 Acute pancreatitis.

    24 Obesity.

    Part Two Liver disease.

    25 Hepatitis C.

    26 Hepatitis B.

    27 Alcoholic liver disease.

    28 Non-alcoholic fatty liver disease.

    29 Hemochromatosis.

    30 Wilson disease.

    31 Primary biliary cirrhosis.

    32 Autoimmune hepatitis.

    33 Primary sclerosing cholangitis.

    34 Non histological assessment of hepatic fibrosis.

    35 Portal hypertensive bleeding.

    36 Hepatic outflow syndromes and splanchnic venous thrombosis.

    37 Ascites, hepatorenal syndrome and spontaneous bacterial peritonitis.

    38 Hepatic encephalopathy.

    39 Hepatocellular carcinoma.

    40 Acute liver failure.

    41 Liver transplantation: prevention and treatment of rejection.

    42 Liver transplantation: prevention and treatment of infection.

    43 Management of HCV infection and liver transplantation.

    44 Management of HBV infection and liver transplantation.

    45 Liver biopsy.

    46 Drug induced liver disease - mechanisms and diagnosis